Sygnature Chemical Services and Heptares Therapeutics Announce Contract Chemistry Collaboration

News   Oct 09, 2009

 
Sygnature Chemical Services and Heptares Therapeutics Announce Contract Chemistry Collaboration
 
 
 

RELATED ARTICLES

What Makes Cancer Cells Metastasize?

News

Metastatic spread of tumor cells from one location in the body to another is the cause of 90 percent of cancer-related deaths.

READ MORE

Revolutionary Imaging Technique Uses CRISPR to Map DNA Mutations

News

The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.

READ MORE

AIDS Vaccine Design: New Data Offers Important Insight

News

New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Informatics & Automation Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE